Connect with us

Hi, what are you looking for?

Health News

Patient in Berlin hospital cured of AIDS

There is a report from Berlin that with the help of stem cells taken from a person who is naturally resistant to the virus and transplanting the same in a man suffering from AIDS, doctors have cured this man of his illness.

Experts however point out that though this may have promising implications, it is not feasible to give millions of infected patients in Africa this treatment and even for those in America with insurance suffering from AIDS in some of the top research hospitals, it may not be within reach. According to Dr.Anthony S. Fauci, National Institute of Allergy and Infectious Diseases director, this is not a very surprising development and is not a practical treatment solution.
The patient who was cured is an American aged 42 years residing in Germany. He is also suffering from leukemia and therefore giving him the stem-cell transplant treatment is justified. The stem cell transplant procedure involves completely eliminating a person’s immune system which includes his bone marrow with the help of drugs and radiation. Ten to thirty percent of patients going in for this transplant do not survive. Another hitch in this is the remote possibility of finding a donor with a perfect tissue match. The donor is also required to have the same genetic mutation which makes the patient resistant to HIV.
However, the fact that this patient has been free from the disease for the past twenty months and is not sustained by any antiretroviral drugs, provides a lot of hope for future therapy and treatment for the deadly AIDS.

You May Also Like

Business

State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...